Being Exclusive

The latest version of the US health bill includes a provision about generic biotech drugs. The version passed by the House Energy and Commerce Committee gives biotech drugs 12-year exclusivity period, reports the Wall Street Journal Health Blog. The chair of the committee, Henry Waxman, earlier this year called for a five-year period of exclusivity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.